X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Kilitch Drugs (India) Ltd.
BSE CODE: 524500   |   NSE CODE: KILITCH   |   ISIN CODE : INE729D01010   |   02-Jul-2025 Hrs IST
BSE NSE
Rs. 449.00
10.65 ( 2.43% )
 
Prev Close ( Rs.)
438.35
Open ( Rs.)
442.40
 
High ( Rs.)
451.90
Low ( Rs.)
442.40
 
Volume
622
Week Avg.Volume
580
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 444.10
2.35 ( 0.53% )
 
Prev Close ( Rs.)
441.75
Open ( Rs.)
444.00
 
High ( Rs.)
450.50
Low ( Rs.)
436.20
 
Volume
15399
Week Avg.Volume
8097
 
52 WK High-Low Range(Rs.)
299.95
499
Source DateBoard Meeting DateDetails
30-Jun-2025 02-Jul-2025 Inter-alia transact the following; 1. To consider and approve the proposal for fund raising by way of issue of equity shares of face value of 10/-each (the ?Equity Shares?) through Rights Issue. 2. To consider and approve the deployment of the proceeds of the Right Issue. 3. To consider and approve the Draft Letter of Offer for fund raising by way of Right issue and to authorize for Application for in-principal approval for rights issue up to %50,00,00,000/- under Regulation 28(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. 4. To consider and transit any other business, if any, which may be placed before the Board with the permission of the Chairman.
13-May-2025 19-May-2025 Quarterly Results & Audited Results
03-Feb-2025 11-Feb-2025 Quarterly Results
04-Nov-2024 12-Nov-2024 Quarterly Results
01-Aug-2024 08-Aug-2024 Quarterly Results
21-May-2024 27-May-2024 Quarterly Results
31-Jan-2024 08-Feb-2024 Quarterly Results
01-Nov-2023 09-Nov-2023 Quarterly Results
04-Aug-2023 11-Aug-2023 Quarterly Results
19-Jul-2023 22-Jul-2023 Inter alia, to consider and approve conversion of warrants into the equity shares of the Company to the specified person only.
Page 1 of 14
PREV || NEXT